Mingjia Li

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Marcelo V. Negrão, Haniel A. Araújo, Giuseppe Lamberti et al. · Cancer Discovery · 2023 · 166 citations · Full text

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

Mingjia Li, Daniel Spakowicz, Jarred Burkart et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 113 citations · Full text

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

Daniel Spakowicz, Rebecca Hoyd, Mitchell Muniak et al. · BMC Cancer · 2020 · 58 citations · Full text

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

Talal El Zarif, Amin H. Nassar, Elio Adib et al. · Journal of Clinical Oncology · 2023 · 55 citations · Full text

Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer

Mingjia Li, Daniel Spakowicz, Songzhu Zhao et al. · Cancer Immunology Immunotherapy · 2020 · 44 citations · Full text

Advanced Cancer, Advanced Lung Disease, Medicine +7